DexCom, Inc. (NASDAQ:DXCM) reported its unaudited financial results for the quarter ended September 30, 2010.
DexCom, Inc. (DXCM) released financial results on Thursday after the market closed that missed Wall Street estimates. DexCom, Inc reported a 3rd quarter net loss of 23 cents per share, on revenue of $10.78 million.
Product revenue grew to approximately $10.8 million for the third quarter of 2010, an increase of approximately 133% from the $4.6 million in product revenue reported for the third quarter of 2009, and an increase of approximately 19% from the $9.0 million in product revenue reported for the second quarter of 2010.
Shares of medical device manufacturer DexCom, Inc. (DXCM) are currently down 21.4% at $10.93 per share during Friday morning trading. Today's trading range for shares of DexCom, Inc (DXCM) has been between $9.94 and $11.69 per share. The consensus price target of analysts covering the company's stock is $14.72 per share.
DexCom, Inc. (DXCM), headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients with diabetes and by healthcare providers in the hospital. DexCom (DXCM) is a medical device company with a limited operating history.
Social Media's #1 Financial Newsletter Reaching Over 105,000 Readers!
Join Our FREE Newsletter! http://stocktwiter.com/
Join us on Twitter!
Disclosure: "No Positions"